Protein arginine methyltransferase 5 (PRMT5) and the ERK1/2 & PI3K pathways: A case for PRMT5 inhibition and combination therapies in cancer

Tzuriel Sapir, David Shifteh, Moshe Pahmer, Sanjay Goel, Radhashree Maitra

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Protein arginine methyltransferase 5 (PRMT5) and the ERK1/2 & PI3K pathways: A case for PRMT5 inhibition and combination therapies in cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences